The aim of the present study was to measure the tumor TNF-alpha, interleukin-1 beta (IL-1 beta), adiponectin, and adropin levels that play a role in systemic inflammation in OSAS patients for determining whether they are related to OSAS or not. The gene discussed is TNF; the disease is neoplasm.